Study protocol: the ILANA study – exploring optimal implementation strategies for long-acting antiretroviral therapy to ensure equity in clinical care and policy for women, racially minoritised people and older people living with HIV in the UK – a qualitative multiphase longitudinal study design

Introduction Cabotegravir and rilpivirine (CAB+RPV long-acting (LA)) is recommended as a treatment for HIV-1 allowing people living with HIV to receive 2 monthly injectable treatment, rather than daily pills. Providing injectable therapy in a system designed to provide and manage study participants...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Sara Paparini, Vanessa Apea, James Hand, Rachel Phillips, Chloe M Orkin, Jenny Scherzer, Sadna Ullah, Hamzah Z Farooq, Bakita Kasadha, Gill Hilton-Smith, Amber Haley
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMJ Publishing Group 2023-07-01
Цуврал:	BMJ Open
Онлайн хандалт:	https://bmjopen.bmj.com/content/13/7/e070666.full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!